EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieÄquivalenzstudieOpen Access · CC BY-NC-ND 4.0

Marshall-Plan Ablation Strategy Versus Pulmonary Vein Isolation in Persistent AF: A Randomized Controlled Trial

Nicolas Derval iD, Romain Tixier iD, Josselin Duchateau iD, Xavier Bouteiller, Timothé Loock, Arnaud Denis, Rémi Chauvel iD, Benjamin Bouyer iD, Marine Arnaud iD, Masaaki Yokoyama iD, Christopher Kowalewski iD, Cinzia Monaco iD und 6 weitere

Circulation: Arrhythmia and Electrophysiology · 2025

DOI: 10.1161/circep.124.013427 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2025. Verfasst von Nicolas Derval und 17 weiteren Autor:innen. Beteiligte Einrichtung: IHU Liryc, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, France (N.D., R.T., J.D., X.B., R.C., B.B., M.A., M.Y., C.K…. Hauptthemen laut MEDLINE: Pulmonary Veins, Atrial Fibrillation, Catheter Ablation. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Beyond pulmonary vein (PV) isolation, the optimal ablation strategy for persistent atrial fibrillation (AF) remains poorly defined. The purpose of this study was to compare 2 ablation strategies in the treatment of patients with persistent AF: a comprehensive ablation strategy based on anatomic considerations versus PV isolation alone. METHODS: The Marshall-Plan trial is a prospective, randomized, parallel-group, controlled clinical trial of superiority conducted at the Bordeaux University Hospital. Consecutive patients with symptomatic, documented persistent AF were included and randomized into 2 arms: Marshall-Plan consisting of PV isolation with additional ablation including vein of Marshall ethanol infusion, and lines of block at the mitral, dome, and cavotricuspid isthmuses versus PV isolation alone. The main outcome was the 1-year freedom from any arrhythmia (atrial fibrillation/atrial tachycardia >30 seconds) after a single ablation procedure with or without any antiarrhythmic medication at 12 months. RESULTS: A total of 120 patients were included (age 65±8 years; 21 women). Two patients were excluded from analysis. All PVs were successfully isolated in both groups. In the Marshall-Plan group, vein of Marshall ethanol infusion was completed in 57 (97%) patients. Conduction block across linear lesions was obtained in 93%, 92%, and 93% of the mitral, dome, and cavotricuspid isthmuses, respectively. The full lesion set was successfully completed in 52 (88%) patients in the Marshall-Plan group and 59 (100%) patients in the PV isolation group. At 12 months, freedom from recurrence of atrial arrhythmia >30 seconds after 1 ablation procedure, with or without antiarrhythmic medication, had occurred in 51 of the 59 (86.4%) patients assigned to the Marshall-Plan approach, and 39 of the 59 (66.1%) patients assigned to PV isolation only ( P =0.012). CONCLUSIONS: In this prospective randomized controlled trial, the Marshall-Plan strategy was significantly superior to a PV isolation strategy at 12 months. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04206982.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary VeinsAtrial FibrillationCatheter AblationHumansFemaleMaleAgedProspective StudiesMiddle AgedTreatment OutcomeHeart RateTime FactorsEthanolRecurrenceAction Potentials

Stichwörter der Autor:innen

cardiac arrhythmiaethanolhearthumanpulmonary veinstachycardiatherapeutics

Substanzen

Ethanol

Autor:innen und Institutionen

  • IHU Liryc, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, France (N.D., R.T., J.D., X.B., R.C., B.B., M.A., M.Y., C.K., C.M., C.A., F.S., M. Hocini, P.J., M. Haïssaguerre, T.P.).
  • Bordeaux University Hospital (CHU), Cardio-Thoracic Unit, France (N.D., R.T., J.D., X.B., T.L., R.C., M.Y., C.K., C.M., C.A., T.P.).
  • Clinique Saint Augustin, France (A.D.).
  • Univ. Bordeaux, Centre de recherche Cardio-Thoracique de Bordeaux, France (B.B., M.A., F.S., M. Hocini, P.J., M. Haïssaguerre).

ORCID-Profile: Nicolas Derval, Romain Tixier, Josselin Duchateau, Rémi Chauvel, Benjamin Bouyer, Marine Arnaud, Masaaki Yokoyama, Christopher Kowalewski, Cinzia Monaco, Ciro Ascione, Frédéric Sacher, Mélèze Hocini, Pierre Jaïs, Michel Haïssaguerre, Thomas Pambrun

Zitieren

APA

Derval, N., Tixier, R., Duchateau, J., Bouteiller, X., Loock, T., Denis, A., Chauvel, R., Bouyer, B., Arnaud, M., Yokoyama, M., Kowalewski, C., Monaco, C., Ascione, C., Sacher, F., Hocini, M., Jaïs, P., Haïssaguerre, M., & Pambrun, T. (2025). Marshall-Plan Ablation Strategy Versus Pulmonary Vein Isolation in Persistent AF: A Randomized Controlled Trial. Circulation: Arrhythmia and Electrophysiology. https://doi.org/10.1161/circep.124.013427

Vancouver

Derval N, Tixier R, Duchateau J, Bouteiller X, Loock T, Denis A, et al. Marshall-Plan Ablation Strategy Versus Pulmonary Vein Isolation in Persistent AF: A Randomized Controlled Trial. Circulation: Arrhythmia and Electrophysiology. 2025. doi:10.1161/circep.124.013427

BibTeX
@article{Derval2025,
  author = {Derval, Nicolas and Tixier, Romain and Duchateau, Josselin and Bouteiller, Xavier and Loock, Timothé and Denis, Arnaud and Chauvel, Rémi and Bouyer, Benjamin and Arnaud, Marine and Yokoyama, Masaaki and Kowalewski, Christopher and Monaco, Cinzia and Ascione, Ciro and Sacher, Frédéric and Hocini, Mélèze and Jaïs, Pierre and Haïssaguerre, Michel and Pambrun, Thomas},
  title = {Marshall-Plan Ablation Strategy Versus Pulmonary Vein Isolation in Persistent AF: A Randomized Controlled Trial},
  journal = {Circulation: Arrhythmia and Electrophysiology},
  year = {2025},
  doi = {10.1161/circep.124.013427}
}
Kostenlos starten →